Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatches reveal hidden heart and mental toll of COVID-19

NCT ID NCT04605965

Knowledge-focused Sponsor: Tulane University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study followed 200 adults who had COVID-19 to see if the virus causes long-term heart problems or mental health issues. Participants wore health-tracking devices and answered surveys about anxiety, depression, and substance use. The goal was to better understand the lasting effects of COVID-19.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could reveal how often COVID-19 leads to long-term heart problems or mental health issues, helping doctors monitor and support survivors.
What could go wrong
This is an observational study, not a treatment trial. It only tracks 200 people, so results may not apply to everyone. Wearable data can be incomplete or inaccurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

200 people

The number who actually took part.

Started

Jun 2020

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with a positive COVID-19 diagnosis.

Ages

18 to 120 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Positive COVID-19 diagnosis * Ages 18 to 120 * Access to WiFi Exclusion Criteria: * Negative COVID-19 diagnosis * Age younger than 18 and older than 120 * Lack of access to WiFi

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Behavioral changes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiovascular disorder COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Behavioral changes Cardiovascular complication COVID19

Contacts and locations

Locations

  • Tulane University

    New Orleans, Louisiana, 70119, United States

  • Tulane University, TRIAD Center

    New Orleans, Louisiana, 70119, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.